|
US2014271839A1
|
|
Extended-release topiramate capsules
|
|
US8785426B1
|
|
Testosterone gel compositions and related methods
|
|
EP2588085A1
|
|
Sustained release composition comprising an amine as active agent and a salt of a cyclic organic acid
|
|
WO2010102245A1
|
|
Solid dispersion comprising resveratrol
|
|
BRPI0923836A2
|
|
Opioid-containing oral pharmaceutical compositions and methods
|
|
US2005059644A1
|
|
Dermatological compositions and methods
|
|
US6977081B1
|
|
Facial cream composition containing allantoin
|
|
US2003171407A1
|
|
Composition for reducing blood glucose and cholesterol
|
|
US6780437B2
|
|
Coated potassium chloride granules and tablets
|
|
US6598368B1
|
|
Cotton holding disk
|
|
US6265391B1
|
|
Method for preventing peripheral nerve damage
|
|
US6423719B1
|
|
Method for treating benign prostate hyperplasia
|
|
US6313131B1
|
|
Method of kidney treatment
|
|
US6607754B1
|
|
Delivery of Hypericum perforatum (St. John's Wort) in tablet form
|
|
US5785995A
|
|
Pharmaceutical tablet of amiodarone salt
|
|
WO9425040A1
|
|
Use of potassium iodide for the treatment of symptomatic benign hyperplasia
|
|
US5268181A
|
|
Method of using niacin to control nocturnal cholesterol synthesis
|
|
KR100234446B1
|
|
Sustained-release tablet containing hydroxypropyl methylcellulose, binder, hydrophobic elements, and water-soluble medicament
|
|
AU1822492A
|
|
Controlled release tablet containing water soluble medicament
|
